Nicola Lo Buono

Years Active: 2017-2020
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Elisa Pozzi, Elisa Giorgio, Cecilia Mancini, Nicola Lo Buono, Stefania Augeri, Marta Ferrero, Eleonora Di Gregorio, Evelise Riberi, Maria Vinciguerra, Lorenzo Nanetti, Federico Tommaso Bianchi, Maria Paola Sassi, Vincenzo Costanzo, Caterina Mariotti, Ada Funaro, Simona Cavalieri, Alfredo Brusco
In vitro dexamethasone treatment does not induce alternative ATM transcripts in cells from Ataxia-Telangiectasia patients. Scientific reports 10 (1) (2020)
Sonia García-Rodríguez, Antonio Rosal-Vela, Davide Botta, Luz M Cumba Garcia, Esther Zumaquero, Verónica Prados-Maniviesa, Daniela Cerezo-Wallis, Nicola Lo Buono, José-Ángel Robles-Guirado, Salvador Guerrero, Elena González-Paredes, Eduardo Andrés León, Ángel Corbí, Matthias Mack, Friedrich Koch-Nolte, Ramón Merino, Mercedes Zubiaur, Frances E Lund, Jaime Sancho
CD38 promotes pristane-induced chronic inflammation and increases susceptibility to experimental lupus by an apoptosis-driven and TRPM2-dependent mechanism. Scientific reports 8 (1) (2018)
Enza Ferrero, Nicola Lo Buono, Simona Morone, Rossella Parrotta, Cecilia Mancini, Alfredo Brusco, Alice Giacomino, Stefania Augeri, Antonio Rosal-Vela, Sonia García-Rodríguez, Mercedes Zubiaur, Jaime Sancho, Alessandra Fiorio Pla, Ada Funaro
Human canonical CD157/Bst1 is an alternatively spliced isoform masking a previously unidentified primate-specific exon included in a novel transcript. Scientific reports 7 (1) (2017)

Nicola Lo Buono.css-eqlu8i{font-size:small;padding-left:4px;}